老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BIONDVAX PHARMACEUTICALS SPON ADS EACH REP 400 ORD SHS(POST SPLT)

1.36
0.0000
成交量：- -
成交額：3.03萬
市值：496.66萬
市盈率：-0.44
高：1.36
開：1.36
低：1.36
收：1.36
資料載入中...
總覽公司新聞公告
2023/06/08

重要事件披露

Form 8-K - Current report
2023/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/11

重要事件披露

8-K - Current report
2023/05/04

重要事件披露

8-K - Current report
2023/05/04

重要事件披露

8-K - Current report
2023/04/17

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/04/17

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/14

SEC問詢函

CORRESP [Cover] - Correspondence
2022/12/14

SEC問詢函

CORRESP [Cover] - Correspondence
2022/12/14

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/12/12

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/10/06

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/29

招股説明書

F-1 - Registration statement for certain foreign private issuers
2022/03/28

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/01/11

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/13

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/06

SEC問詢函

CORRESP [Cover] - Correspondence
更多